EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 57 / No 4 (December 2025) J Extra Corpor Technol, 57 4 (2025) 243-262 References
Open Access
Review
Issue
J Extra Corpor Technol
Volume 57, Number 4, December 2025
Page(s) 243 - 262
DOI https://doi.org/10.1051/ject/2025033
Published online 17 December 2025
  1. Hill JD, O’Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med. 1972;286(12):629–634. [Google Scholar]
  2. Abrams D, Brodie D, Arcasoy SM. Extracorporeal life support in lung transplantation. Clin Chest Med. 2017;38(4):655–666. [Google Scholar]
  3. Castleberry AW, Hartwig MG, Whitson BA. Extracorporeal membrane oxygenation post lung transplantation. Curr Opin Organ Transplant. 2013;18(5):524–530. [Google Scholar]
  4. Szentgyorgyi L, Head L, Dosouto E, Shah R, Davies A. Post-intubation tracheal tear repair on VV-ECMO support. J Cardiothoracic Vasc Anesth. 2018;32:S74. [Google Scholar]
  5. Szentgyorgyi L, Ioannis D, Feddy L, Garcia M, Shah R, Granato F. Intraoperative iatrogenic tracheal repair on VV-ECMO support (EuroELSO 2018 Abstracts). Perfusion. 2018;33 (1_suppl):87–220. [Google Scholar]
  6. Eadington T, Taylor M, Shah R, Granato F, Venkateswaran R, Szentgyorgyi L. Veno-venous extracorporeal membrane oxygenation used as an adjunct in the surgical management of acquired and iatrogenic tracheobronchial pathology. Minerva Surg. 2022;77(6):542–549. [Google Scholar]
  7. Harvey W. An anatomical disquisition on the motion of the heart & blood in animals. United Kingdom: J. M. Dent & Co.; 1906. [Google Scholar]
  8. Fye WB. Julien Jean Cesar Legallois. Clin Cardiol. 1995;18(10):599–600. [Google Scholar]
  9. Boettcher W, Merkle F, Weitkemper HH. History of extracorporeal circulation: the conceptional and developmental period. J Extra Corpor Technol. 2003;35(3):172–183. [Google Scholar]
  10. Hessel EA 2nd. A brief history of cardiopulmonary bypass. Semin Cardiothorac Vasc Anesth. 2014;18(2):87–100. [Google Scholar]
  11. Combes A, Vuylsteke A, Brodie D, Peek G, Fowles J-A. A brief history of ECMO, in: ECMO in the Adult Patient. Core Critical Care. Cambridge: Cambridge University Press; 2017: 1–8. [Google Scholar]
  12. Intensive. @intensiveblog.com; 2021. 2021–08-04. Available from: https://intensiveblog.com/the-history-of-ecmo/. [Google Scholar]
  13. Iwahashi H, Yuri K, Nose Y. Development of the oxygenator: past, present, and future. J Artif Organs. 2004;7(3):111–120. [Google Scholar]
  14. Sangalli FM, Marzorati C, Rana NK. History of Extracorporeal Life Support. In: Sangalli FP, Patroniti N, Pesenti A, Eds. ECMO-Extracorporeal Life Support in Adults. Springer Milan Heidelberg New York Dordrecht London: Springer-Verlag Italia; 2014:3–11. [Google Scholar]
  15. Stoney WS. Evolution of cardiopulmonary bypass, Circulation. 2009;119(21):2844–2853. [CrossRef] [PubMed] [Google Scholar]
  16. Mustard WT, Chute AL, Keith JD, Sirek A, Rowe RD, Vlad P. A surgical approach to transposition of the great vessels with extracorporeal circuit. Surgery. 1954;36(1):31–51. [Google Scholar]
  17. Lillehei CW, Warden HE, Dewall RA, Stanley P, Varco RL. Cardiopulmonary by-pass in surgical treatment of congenital or acquired cardiac disease; use in three hundred five patients. AMA Arch Surg. 1957;75(6):928–945. [Google Scholar]
  18. Drew CE, Anderson IM. Profound hypothermia in cardiac surgery: report of three cases. Lancet. 1959;1(7076):748–750. [Google Scholar]
  19. Dewall RA, Gott VL, Lillehei CW, et al. A simple, expendable, artificial oxygenator for open heart surgery. Surg Clin North Am. 1956;36(4):1025–1034. [CrossRef] [Google Scholar]
  20. Cooley DA, Belmonte BA, Latson JR, Pierce JF. Bubble diffusion oxygenator for cardiopulmonary by-pass. J Thorac Surg. 1958;35(1):131–134. [Google Scholar]
  21. Passaroni AC, Silva MA, Yoshida WB. Cardiopulmonary bypass: development of John Gibbon’s heart-lung machine. Rev Bras Cir Cardiovasc. 2015;30(2):235–245. [Google Scholar]
  22. Maybauer MO, Jiritano F, Lorusso R. From the first ECMO patient into the future. In: Maybauer MO, Maybauer MO, (Eds.), Extracorporeal Membrane Oxygenation. Oxford: Oxford University Press; 2022: 3–12. [Google Scholar]
  23. Yeager T, Roy S. Evolution of gas permeable membranes for extracorporeal membrane oxygenation. Artif Organs. 2017;41(8):700–709. [CrossRef] [Google Scholar]
  24. Featherstone PJ, Ball CM. The early history of extracorporeal membrane oxygenation. Anaesth Intensive Care. 2018;46(6):555–557. [Google Scholar]
  25. Rashkind WJ, Freeman A, Klein D, Toft RW. Evaluation of a disposable plastic, low volume, pumpless oxygenator as a lung substitute. J Pediatr. 1965;66:94–102. [Google Scholar]
  26. Hill JD, Bramson ML, Rapaport E, Scheinman M, Osborn JJ, Gerbode F. Experimental and clinical experiences with prolonged oxygenation and assisted circulation. Ann Surg. 1969;170(3):448–459. [Google Scholar]
  27. Bonacchi M. Extracorporeal life support in polytraumatized patients. Int J Surg. 2016;33(Pt B):213–217. [Google Scholar]
  28. Bartlett RH. Esperanza: The first Neonatal ECMO patient. ASAIO J. 2017;63(6):832–843. [Google Scholar]
  29. Wolfson PJ. The development and use of extracorporeal membrane oxygenation in neonates. Ann Thorac Surg. 2003;76(6):S2224–S2229. [CrossRef] [Google Scholar]
  30. Lim MW. The history of extracorporeal oxygenators. Anaesthesia. 2006;61(10):984–995. [Google Scholar]
  31. He T, Yu S, He J, et al. Membranes for extracorporeal membrane oxygenator (ECMO): History, preparation, modification and mass transfer. Chin J Chem Eng. 2022;49:46–75. [Google Scholar]
  32. Mortensen JD. An intravenacaval blood gas exchange (IVCBGE) device. A preliminary report. ASAIO Trans. 1987;33(3):570–573. [Google Scholar]
  33. Mortensen JD. Intravascular oxygenator: a new alternative method for augmenting blood gas transfer in patients with acute respiratory failure. Artif Organs. 1992;16(1):75–82. [Google Scholar]
  34. Conrad SA, Bagley A, Bagley B, Schaap RN. Major findings from the clinical trials of the intravascular oxygenator. Artif Organs. 1994;18(11):846–863. [Google Scholar]
  35. Straube TL, Farling S, Deshusses MA, Klitzman B, Cheifetz IM, Vesel TP. Intravascular gas exchange: physiology, literature review, and current efforts. Respir Care. 2022;67(4)480–493. [Google Scholar]
  36. Wheeldon D. Intravascular oxygenation. Perfusion. 1994;9(3):181–188. [Google Scholar]
  37. Zwischenberger JB, Tao W, Cardenas VJ, Bidani A. Intravascular membrane oxygenation and carbon dioxide removal with permissive hypercapnia – new concepts in the management of respiratory failure. In: Unger F, Ed. Assisted Circulation 4. Berlin, Heidelberg: Springer Berlin Heidelberg; 1995:336–352. [Google Scholar]
  38. Kim GB, Kwon TK, Hung CU. Design of an intravenous oxygenator. J Artif Organs. 2006;9(1):34–41. [Google Scholar]
  39. Wenger RK, Mortensen JD. The intravascular oxygenator, IVOX®: augmentation of blood-gas transfer. In: Mora CT, Guyton RA, Finlayson DC, Rigatti RL, Eds. Cardiopulmonary Bypass. New York, NY: Springer New York; 1995: 450–458. [Google Scholar]
  40. Zwischenberger JB, Nguyen TT, Tao W, et al. IVOX with gradual permissive hypercapnia: a new management technique for respiratory failure. J Surg Res. 1994;57(1):99–105. [Google Scholar]
  41. Kallis P, Al-Saady NM, Bennett ED, Treasure T. Early results of intravascular oxygenation, Eur J Cardiothorac Surg. 1993;7(4):206–210. [Google Scholar]
  42. Gentilello LM, Jurkovich GJ, Gubler KD, Anardi DM, Heiskell R. The intravascular oxygenator (IVOX): preliminary results of a new means of performing extrapulmonary gas exchange. J Trauma. 1993;35(3):399–404. [Google Scholar]
  43. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al.. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979;242(20):2193–2196. [CrossRef] [PubMed] [Google Scholar]
  44. Bartlett RH. Extracorporeal life support: history and new directions. Semin Perinatol. 2005;29(1)2–7. [Google Scholar]
  45. Kolobow T, Gattinoni L, Tomlinson TA, Pierce JE. Control of breathing using an extracorporeal membrane lung. Anesthesiology. 1977;46(2):138–141. [Google Scholar]
  46. Gattinoni L, Agostoni A, Pesenti A, et al. Treatment of acute respiratory failure with low-frequency positive-pressure ventilation and extracorporeal removal of CO2. Lancet. 1980;2(8189):292–294. [Google Scholar]
  47. Gattinoni L, Pesenti A, Mascheroni D, et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA. 1986;256(7):881–886. [Google Scholar]
  48. Kolobow T, Gattinoni L, Tomlinson T, White D, Pierce J, Iapichino G. The carbon dioxide membrane lung (CDML): a new concept. Trans Am Soc Artif Intern Organs. 1977;23:17–21. [Google Scholar]
  49. Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994;149(2 Pt 1):295–305. [CrossRef] [PubMed] [Google Scholar]
  50. Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 1985;76(4):479–487. [Google Scholar]
  51. O’Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics. 1989;84(6):957–963. [Google Scholar]
  52. Toomasian JM, Snedecor SM, Cornell RG, Cilley RE, Bartlett RH. National experience with extracorporeal membrane oxygenation for newborn respiratory failure. Data from 715 cases. ASAIO Trans, 1988;34(2):140–147. [Google Scholar]
  53. Bartlett RH, Andrews AF, Toomasian JM, Haiduc NJ, Gazzaniga AB. Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases. Surgery. 1982;92(2):425–433. [Google Scholar]
  54. Schumacher RE, Roloff DW, Chapman R, Snedecor S, Bartlett RH. Extracorporeal membrane oxygenation in term newborns. A prospective cost-benefit analysis. ASAIO J. 1993;39(4):873–879. [CrossRef] [PubMed] [Google Scholar]
  55. UK Collaborative ECMO Trail Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348(9020):75–82. [CrossRef] [PubMed] [Google Scholar]
  56. ELSO. Extracorporeal Life Support Organization (ELSO) Worldwide Directory of ECMO and ECLS Centers: Extracorporeal Life Support Organization; 2024. Available from: https://www.elso.org/membership/centerdirectory.aspx. [Google Scholar]
  57. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–1363. [CrossRef] [PubMed] [Google Scholar]
  58. Australia, New Zealand Extracorporeal Membrane Oxygenation Influenza I, Davies A, Jones D, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome, JAMA. 2009;302(17):1888–1895. [CrossRef] [PubMed] [Google Scholar]
  59. Warren A, Chiu YD, Villar SS, et al. Outcomes of the NHS England National Extracorporeal Membrane Oxygenation Service for adults with respiratory failure: a multicentre observational cohort study. Br J Anaesth. 2020;125(3):259–266. [Google Scholar]
  60. Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965–1975. [CrossRef] [PubMed] [Google Scholar]
  61. Tasaka S, Ohshimo S, Takeuchi M, et al. ARDS Clinical Practice Guideline 2021. J Intensive Care. 2022;10(1):32. [Google Scholar]
  62. Melchior RW, Sutton SW, Harris W, Dalton HJ. Evolution of membrane oxygenator technology for utilization during pediatric cardiopulmonary bypass. Pediatric Health Med Ther. 2016;7:45–56. [Google Scholar]
  63. MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med. 2012;38(2):210–220. [Google Scholar]
  64. Johnson KN, Carr B, Mychaliska GB, Hirschl RB, Gadepalli SK. Switching to centrifugal pumps may decrease hemolysis rates among pediatric ECMO patients. Perfusion. 2022;37(2):123–127. [Google Scholar]
  65. Palanzo D, Qiu F, Baer L, Clark JB, Myers JL, Undar A. Evolution of the extracorporeal life support circuitry. Artif Organs. 2010;34(11):869–873. [Google Scholar]
  66. Palanzo DA, Baer LD, El-Banayosy A, Wang S, Undar A, Pae WE. Choosing a pump for extracorporeal membrane oxygenation in the USA. Artif Organs. 2014;38(1):1–4. [Google Scholar]
  67. Undar A, Kunselman AR, Barbaro RP, Alexander P, Patel K, Thomas NJ. Centrifugal or roller blood pumps for neonatal venovenous extracorporeal membrane oxygenation: extracorporeal life support organization database comparison of mortality and morbidity. Pediatr Crit Care Med. 2023;24(8):662–669. [Google Scholar]
  68. O’Halloran CP, Thiagarajan RR, Yarlagadda VV, et al. Outcomes of infants supported with extracorporeal membrane oxygenation using centrifugal versus roller pumps: an analysis from the extracorporeal life support organization registry. Pediatr Crit Care Med. 2019;20(12):1177–1184. [Google Scholar]
  69. Zeidman AD. Extracorporeal membrane oxygenation and continuous kidney replacement therapy: technology and outcomes – a narrative review. Adv Chronic Kidney Dis. 2021;28(1):29–36. [Google Scholar]
  70. Askenazi DJ, Selewski DT, Paden ML, et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol. 2012;7(8):1328–1336. [Google Scholar]
  71. Van Dyk M. The use of CRRT in ECMO patients. Egypt J Crit Care Med. 2018;6(3):95–100. [Google Scholar]
  72. Supady A, Brodie D, Wengenmayer T. Extracorporeal haemoadsorption: does the evidence support its routine use in critical care? Lancet Respir Med. 2022;10(3):307–312. [Google Scholar]
  73. Schmidt M, Jaber S, Zogheib E, Godet T, Capellier G, Combes A. Feasibility and safety of low-flow extracorporeal CO(2) removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS. Crit Care. 2018;22(1):122. [Google Scholar]
  74. PrismaLung+ manufacturer’s website: Baxter International Inc.; 2025. Available from: https://emeaacutetherapies.baxter.com/prismalung. [Google Scholar]
  75. Nishida H, Endo M, Koyanagi H, Suzuki S, Kuwana K, Nakanishi H. Oxygenator with built-in hemoconcentrator: a new concept. Artif Organs. 1995;19(4):365–368. [Google Scholar]
  76. Nishida H, Suzuki S, Endo M, et al. Laboratory evaluation of a new membrane oxygenator with a built-in hemoconcentrator. J Extra Corpor Technol. 1997;29(4):189–193. [Google Scholar]
  77. Bain JC, Turner DA, Rehder KJ, et al. Economic outcomes of extracorporeal membrane oxygenation with and without ambulation as a bridge to lung transplantation. Respir Care. 2016;61(1):1–7. [Google Scholar]
  78. Abrams D, Garan AR, Brodie D. Awake and fully mobile patients on cardiac extracorporeal life support. Ann Cardiothorac Surg. 2019;8(1):44–53. [Google Scholar]
  79. Lee SH. Awakening in extracorporeal membrane oxygenation as a bridge to lung transplantation. Acute Crit Care 2022;37(1):26–34. [Google Scholar]
  80. Rorro F, Broman LM, Prahl Wittberg L. Performance comparison of centered and tilted blunt and lighthouse tip cannulae for drainage in extracorporeal life support. Cardiovasc Eng Technol. 2025;16(2):238–250. [Google Scholar]
  81. Parker LP, Fiusco F, Rorro F, et al. Venovenous extracorporeal membrane oxygenation drainage cannula performance: From generalized to patient-averaged vessel model. Phys Fluids. 2024;36(6):061912. [Google Scholar]
  82. Venous Return Cannulae, Single Stage, Straight Lighthouse Tip Livanova.com: LivaNova, Inc.; 2025. Available from: https://www.livanova.com/cannulae/en-gb/pediatric/venous-return-cannulae/single-stage/straight-lighthouse-tip-wire-reinforced-tubing. [Google Scholar]
  83. Avalon Elite Bi-Caval Dual Lumen Catheter Getinge.com: Getinge AB; 2025. Available from: https://www.getinge.com/uk/products/avalon-elite-catheter/. [Google Scholar]
  84. ProtekDuo Kit Livanova.com: LivaNova, Inc.; 2025. Available from: https://www.livanova.com/advanced-circulatory-support/en-us/protekduo-kit. [Google Scholar]
  85. Maybauer MO, Koerner MM, Swol J, El Banayosy A, Maybauer DM. The novel ProtekDuo ventricular assist device: Configurations, technical aspects, and present evidence. Perfusion. 2023;38(5):887–893. [Google Scholar]
  86. John KJ, Nabzdyk CGS, Chweich H, Mishra AK, Lal A. ProtekDuo percutaneous ventricular support system-physiology and clinical applications. Ann Transl Med. 2024;12(1):14. [Google Scholar]
  87. Brewer JM, Maybauer MO. The ProtekDuo Cannula: a comprehensive review of efficacy and clinical applications in right ventricular failure, J Clin Med. 2024;13(14):4077. [Google Scholar]
  88. Ruhparwar A, Zubarevich A, Osswald A, et al. ECPELLA 2.0-Minimally invasive biventricular groin-free full mechanical circulatory support with Impella 5.0/5.5 pump and ProtekDuo cannula as a bridge-to-bridge concept: A first-in-man method description. J Card Surg. 2020;35(1):195–199. [Google Scholar]
  89. Maybauer MO, Swol J, Sharif A, Benson C, Brewer JM. The ProtekDuo in percutaneous peripheral venopulmonary-arterial ECMO and PROpella configuration for cardiogenic shock with biventricular failure. Ann Card Anaesth. 2023;26(3):339–342. [Google Scholar]
  90. Gennari M, L’Acqua C, Rubino M, et al. Veno-arterial extracorporeal membrane oxygenation in the adult: a bridge to the state of the art. Curr Cardiol Rev. 2021;17(4):e290421188337. [Google Scholar]
  91. Jiritano F, Lo Coco V, Matteucci M, Fina D, Willers A, Lorusso R. Temporary mechanical circulatory support in acute heart failure. Card Fail Rev. 2020;6:e01. [Google Scholar]
  92. Wallinder A, Pellegrino V, Fraser JF, McGiffin DC. ECMO as a bridge to non-transplant cardiac surgery. J Card Surg. 2017;32(8):514–521. [Google Scholar]
  93. Patel B, Diaz-Gomez JL, Ghanta RK, Bracey AW, Chatterjee S. Management of extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Anesthesiology 2021;135(3):497–507. [Google Scholar]
  94. Mohite PN, Sabashnikov A, Koch A, et al. Comparison of temporary ventricular assist devices and extracorporeal life support in post-cardiotomy cardiogenic shock. Interact Cardiovasc Thorac Surg. 2018;27(6):863–869. [Google Scholar]
  95. Akbik B, Chou LP, Gorthi J. Extracorporeal membrane oxygenation in postcardiotomy cardiogenic shock. Methodist Debakey Cardiovasc J. 2023;19(4):66–73. [Google Scholar]
  96. Ariyaratnam P, McLean LA, Cale AR, Loubani M. Extra-corporeal membrane oxygenation for the post-cardiotomy patient. Heart Fail Rev. 2014;19(6):717–725. [Google Scholar]
  97. Wengenmayer T, Tigges E, Staudacher DL. Extracorporeal cardiopulmonary resuscitation in 2023. Intensive Care Med Exp (2023) 11(1):74. [Google Scholar]
  98. Kalra R, Kosmopoulos M, Goslar T, Raveendran G, Bartos JA, Yannopoulos D. Extracorporeal cardiopulmonary resuscitation for cardiac arrest. Curr Opin Crit Care. 2020;26(3):228–235. [Google Scholar]
  99. D’Ettore N, Cardinale A, Maj G, et al. ECPella 5+ in patients with cardiogenic shock: potential for improved outcomes. J Cardiothorac Vasc Anesth. 2025;39(6):1526–1533. [Google Scholar]
  100. Schrage B, Becher PM, Bernhardt A, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an International, Multicenter Cohort Study. Circulation. 2020;142(22):2095–2106. [Google Scholar]
  101. Meani P, Lorusso R, Pappalardo F. ECPella: concept, physiology and clinical applications. J Cardiothorac Vasc Anesth. 2022;36(2):557–566. [Google Scholar]
  102. Kumar KM. ECPR-extracorporeal cardiopulmonary resuscitation. Indian J Thorac Cardiovasc Surg. 2021;37(Suppl 2):294–302. [Google Scholar]
  103. Bartos JA, Frascone RJ, Conterato M, et al. The Minnesota mobile extracorporeal cardiopulmonary resuscitation consortium for treatment of out-of-hospital refractory ventricular fibrillation: Program description, performance, and outcomes. EClinicalMedicine. 2020;29–30:100632. [Google Scholar]
  104. Harris P, Kuppurao L. Ventricular assist devices. Continuing Education in anaesthesia. Crit Care Pain. 2012;12(3):145–151. [Google Scholar]
  105. Upadhyay R, Alrayes H, Arno S, Kaushik M, Basir MB. Current landscape of temporary percutaneous mechanical circulatory support technology. US Cardiol. 2021;15:e21. [Google Scholar]
  106. Vranckx P, Meliga E, De Jaegere PP, Van den Ent M, Regar ES, Serruys PW. The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience. EuroIntervention. 2008;4(3):331–337. [Google Scholar]
  107. Cardiohelp System manufacturer’s website: Getinge AB. 2024. Available from: https://www.getinge.com/int/products/cardiohelp-system/. [Google Scholar]
  108. CentriMag Acute Mechanical Circulatory Support Information | Abbott manufacturer’s website: Abbott Laboratories; 2024. Available from: https://www.cardiovascular.abbott/us/en/hcp/products/heart-failure/mechanical-circulatory-support/centrimag-acute-circulatory-support-system/about.html. [Google Scholar]
  109. Novalung ECMO Machine | Fresenius Medical Care manufacturer’s website: Fresenius Medical Care AG; 2024. Available from: https://fmcna.com/products/novalung-ecmo-therapy/novalung/?tabId=tab-2#tabs-dd3a73a309-item-52bd1278dd-tab. [Google Scholar]
  110. Novalung kits manufacturer’s website: Fresenius Medical Care AG; 2024. Available from: https://www.xenios-ag.com/ecls-with-xenios-console/patient-kits/. [Google Scholar]
  111. The Mobybox System manufacturer’s website: Hemovent GmbH; 2024. Available from: https://www.hemovent.com/eu/. [Google Scholar]
  112. Ontaneda A, Annich GM. Novel surfaces in extracorporeal membrane oxygenation circuits. Front Med (Lausanne) 2018;5:321. [Google Scholar]
  113. Zhang M, Pauls JP, Bartnikowski N, et al. anti-thrombogenic surface coatings for extracorporeal membrane oxygenation: a narrative review. ACS Biomater Sci Eng. 2021;7(9):4402–4419. [Google Scholar]
  114. Gott VL, Whiffen JD, Dutton RC. Heparin bonding on colloidal graphite surfaces. Science 1963;142(3597):1297–1298. [Google Scholar]
  115. Gravlee GP. Heparin-coated cardiopulmonary bypass circuits. J Cardiothorac Vasc Anesth. 1994;8(2):213–222. [Google Scholar]
  116. von Segesser LK. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support. Ann Thorac Surg. 1996;61(1):330–335; discussion 40-1. [Google Scholar]
  117. Pappalardo F, Maj G, Scandroglio A, Sampietro F, Zangrillo A, Koster A. Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated. Perfusion. 2009;24(2):135–137. [CrossRef] [PubMed] [Google Scholar]
  118. Koster A, Sanger S, Hansen R, et al. Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. ASAIO J. 2000;46(3):319–322. [CrossRef] [PubMed] [Google Scholar]
  119. Bellomo TR, Jeakle MA, Meyerhoff ME, Bartlett RH, Major TC. The effects of the combined argatroban/nitric oxide-releasing polymer on platelet microparticle-induced thrombogenicity in coated extracorporeal circuits. ASAIO J. 2021;67(5):573–582. [Google Scholar]
  120. Gerling K, Olschlager S, Avci-Adali M, et al. A novel C1-esterase inhibitor oxygenator coating prevents FXII Activation in human blood. Biomolecules. 2020;10(7):1042. [Google Scholar]
  121. He T, He J, Wang Z, Cui Z. Modification strategies to improve the membrane hemocompatibility in extracorporeal membrane oxygenator (ECMO). Adv Compos Hybrid Mater. 2021;4(4):847–864. [Google Scholar]
  122. Reynolds MM, Annich GM. The artificial endothelium. Organogenesis. 2011;7(1):42–49. [Google Scholar]
  123. El-Ferzli GT, Andukuri A, Alexander G, , et al. A nitric oxide-releasing self-assembled peptide amphiphile nanomatrix for improving the biocompatibility of microporous hollow fibers. ASAIO J. 2015;61(5):589–595. [Google Scholar]
  124. Fallon BP, Lautner-Csorba O, Major TC, et al. Extracorporeal life support without systemic anticoagulation: a nitric oxide-based non-thrombogenic circuit for the artificial placenta in an ovine model. Pediatr Res. 2024;95(1):93–101. [Google Scholar]
  125. Pant J, Goudie MJ, Hopkins SP, Brisbois EJ, Handa H. Tunable nitric oxide release from S-Nitroso-N-acetylpenicillamine via catalytic copper nanoparticles for biomedical applications. ACS Appl Mater Interfaces. 2017;9(18):15254–15264. [Google Scholar]
  126. Eytan D, Bitterman Y, Annich GM. VV extracorporeal life support for the Third Millennium: will we need anticoagulation? J Thorac Dis. 2018;10(Suppl 5):S698–S706. [Google Scholar]
  127. Wang YB, Shi KH, Jiang HL, Gong YK. Significantly reduced adsorption and activation of blood components in a membrane oxygenator system coated with crosslinkable zwitterionic copolymer. Acta Biomater. 2016;40:153–161. [Google Scholar]
  128. Amoako K, Ukita R, Cook KE. Antifouling zwitterionic polymer coatings for blood-bearing medical devices. Langmuir. 2025;41(5):2994–3006. [Google Scholar]
  129. Anton-Martin P, Darnell-Bowens C, Aquino VM, Jones T, Raman L. Successful engraftment after hematopoietic stem cell transplantation with infusion of donor stem cells through the extracorporeal membrane oxygenation circuit. Indian J Crit Care Med. 2016;20(10):617–619. [Google Scholar]
  130. Cao JK, Hong XY, Feng ZC, Li QP. Mesenchymal stem cells-based therapies for severe ARDS with ECMO: a review. Intensive Care Med Exp. 2024;12(1):12. [Google Scholar]
  131. Qutob R, Ji X, Assanangkornchai N, et al. Allogeneic hematopoietic stem cell transplant infusion during venovenous extracorporeal membrane oxygenation support. Crit Care Explor 2021;3(10):e551. [Google Scholar]
  132. Alabdullh HA, Pflaum M, Malzer M, et al. Biohybrid lung development: towards complete endothelialization of an assembled extracorporeal membrane oxygenator. Bioengineering (Basel). 2023;10(1):72. [Google Scholar]
  133. Hellmann A, Klein S, Hesselmann F, et al. EndOxy: Mid-term stability and shear stress resistance of endothelial cells on PDMS gas exchange membranes. Artif Organs. 2020;44(10):E419–E433. [Google Scholar]
  134. Dietrich M, Finocchiaro N, Olszweski S, et al. ENDOXY – Development of a Biomimetic Oxygenator-Test-Device. PLoS One. 2015;10(12):e0142961. [Google Scholar]
  135. Pflaum M, Kuhn-Kauffeldt M, Schmeckebier S, et al. Endothelialization and characterization of titanium dioxide-coated gas-exchange membranes for application in the bioartificial lung. Acta Biomater. 2017;50:510–521. [Google Scholar]
  136. Syed A, Kerdi S, Qamar A. Bioengineering progress in lung assist devices. Bioengineering (Basel). 2021;8(7):89. [Google Scholar]
  137. Zwischenberger JB, Anderson CM, Cook KE, Lick SD, Mockros LF, Bartlett RH. Development of an implantable artificial lung: challenges and progress. ASAIO J. 2001;47(4):316–320. [Google Scholar]
  138. Naito N, Cook K, Toyoda Y, Shigemura N. Artificial lungs for lung failure: JACC Technology Corner. J Am Coll Cardiol. 2018;72(14):1640–1652. [Google Scholar]
  139. Chambers S, Merz SI, McGillicuddy JW, Bartlett R. Development of the MC3 BioLung™ 1581-2, Vol. 2; 2002. [Google Scholar]
  140. Schewe RE, Khanafer KM, Arab A, Mitchell JA, Skoog DJ, Cook KE. Design and in vitro assessment of an improved, low-resistance compliant thoracic artificial lung. ASAIO J. 2012;58(6):583–589. [Google Scholar]
  141. Stephens AF, Seman M, Diehl A, et al. ECMO PAL: using deep neural networks for survival prediction in venoarterial extracorporeal membrane oxygenation. Intensive Care Med. 2023;49(9):1090–1099. [Google Scholar]
  142. Lu Y, Wu H, Qi S, Cheng K. Artificial intelligence in intensive care medicine: toward a ChatGPT/GPT-4 Way? Ann Biomed Eng. 2023;51(9):1898–1903. [Google Scholar]
  143. Bartlett RH. ECMO: The next ten years. Egypt J Crit Care Med. 2016;4(1):7–10. [Google Scholar]
  144. Hoganson DM, Gazit AZ, Boston US, et al. Paracorporeal lung assist devices as a bridge to recovery or lung transplantation in neonates and young children. J Thorac Cardiovasc Surg. 2014;147(1):420–426. [Google Scholar]
  145. Griffith BP, Wu ZJ, Zhang J. Pasta for all: Abiomed Breethe extracorporeal membrane oxygenation system. JTCVS Open. 2021;8:108–113. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.